The interaction of liposomes with the complement system

Critical Reviews in Therapeutic Drug Carrier Systems

Volumn 15, Issue 1, 1998, Pages 57-88

  Szebeni, János ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

Anaphylatoxins; Bilayer membranes; C3a; C5a; Cholesterol; Complement; Liposomes; Phospholipid

Indexed keywords

COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; DRUG CARRIER; LIPOSOME;

COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT SYSTEM; DRUG DELIVERY SYSTEM; HUMAN; IMMUNOASSAY; IMMUNOPHARMACOLOGY; NONHUMAN; OPSONIZATION; REVIEW; SPECIES DIFFERENCE;

EID: 0031935924     PISSN: 07434863     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevtherdrugcarriersyst.v15.i1.20     Document Type: Review

References (194)

1. Alving, C. R., Immunologic aspects of liposomes: Presentation and processing of liposomal protein and phospholipid antigens, Biochim. Biophys. Acta, 1113, 307, 1992.
2. Alving, C. R., Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants, Immunobiology, 187, 430, 1993.
3. Alving, C. R., Shichijo, S., Mattsby-Baltzer, I., Richards, R. L., and Wassef, N. M., Preparation and use of liposomes in immunological studies, in Liposome Technology, 2nd edition, Gregoriadis, G., Ed., Boca Raton, FL: CRC Press, 1993, 317.
4. Alving, C. R., Koulchin, V., Clenn C. M., and Rao M., Liposomes as carriers of peptide antigens: Induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides, Immunol. Rev., 145, 5, 1995.
5. Juliano, R. L., Interaction of proteins and drugs with liposomes, in Liposomes, Ostro, M. J., Ed., New York: Marcel Dekker, 1983, 53.
6. Scherphof, G. I., Damen, J., and Wilschut J., Interaction of liposomes with plasma proteins, in Liposome Technology, Gregoriadis, G., Ed., Boca Raton, FL: CRC Press, 1984, 205.
7. Senior, J. and Gregoriadis, G., Methodology in assessing liposomal stability in the presence of blood, clearance from the circulation of injected animals, and uptake by tissues, in Liposome Technology, Gregoriadis, G., Ed., Boca Raton, FL: CRC Press, 1984, 263.
8. Bonte, F. and Juliano, R. L., Interactions of liposomes with serum proteins. Chem. Phys. Lipids, 40, 359, 1986.
9. Senior, J. H., Fate and behavior of liposomes in vivo: A review of controlling factors, Crit. Rev. Ther. Drug Carrier Syst., 3, 123, 1987.
10. Hernandez-Caselles, T., Villalain J., and Gomez-Fernandez J. C., Influence of liposome charge and composition on their interaction with human blood serum proteins, Mol. Cell. Biochem., 120, 119, 1993.
11. Harashima, H., Ochi, Y., and Kiwada, H., Kinetic modeling of liposome degradation in serum: Effect of size and concentration of liposomes in vitro, Biopharm. Drug Dispos., 15, 217, 1994.
12. Harashima, H., Sakata, K., Funato, K., and Kiwada, H., Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes, Pharm. Res., 11, 402, 1994.
13. Devine, D. V., Wong, K., Serrano, K., Chonn, A., and Cullis, P. R., Liposome-complement interactions in rat serum: Implications for liposome survival studies, Biochim. Biophys. Acta, 1191, 43, 1994.
14. Oja, C. D., Semple, S. C., Chonn, A., and Cullis, P. R., Influence of dose on liposome clearance: Critical role of blood protein, Biochim. Biophys. Acta, 1281, 31, 1996.
15. Chonn, A., Cullis, P. R., and Devine, D. V., The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes, J. Immunol., 146, 4234, 1991.
16. Funato, K., Yamashita, C., Kamada, J.,Tominaga, S.,and Kiwada, H., Plasma factor triggering alternative complement pathway activation by liposomes, Pharmaceut. Res., 11, 372, 1994.
17. Szebeni, J., Wassef, N. M., Hartman, K. R., Rudolph, A. S., and Alving, C. R., Complement activation in vitro by the red blood cell substitute, liposome-encapsulated hemoglobin: Mechanism of activation and inhibition by soluble complement receptor type 1, Transfusion, 37, 150, 1997.
18. Brown, E. J., Joiner, K. A., and Frank, M. M., Complement, in Fundamental Immunology, Paul, W. E., Ed., New York: Raven Press, 1984.
19. Podack, E. R., Cytolytic Lymphocytes and Complement: Effectors of the Immune System, Volume I, Boca Raton, FL: CRC Press, 1988, 3.
20. Halkier, T., Overview of the complement system, in Mechanisms in Blood Coagulation, Fibrinolysis and Complement Activation, Cambridge University Press, Cambridge, 1991, 163.
21. Law, S. K. A. and Reid, K. B. M., Complement. Washington, DC: IRL Press, Oxford, 1994.
22. Morgan, B. P., Physiology and pathophysiology of complement: Progress and trends, Crit. Rev. Clin. Lab. Sci., 32, 265, 1995.
23. Haxby, J. A., Kinsky, C. B., and Kinsky, S. C., Immune response of a liposomal model membrane, Proc. Natl. Acad. Sci. USA, 61, 300, 1968.
24. Haxby, J. A., Gotze, O., Muller-Eberhard, H. J., and Kinsky S. C., Release of trapped marker from liposomes by the action of purified complement components, Proc. Natl. Acad. Sci. USA, 64, 290, 1969.
25. Kinsky, S. C., Haxby, J. A., Zopf, D. A., Alving, C. R., and Kinsky, C. B., Complement-dependent damage to liposomes prepared from pure lipids and Forssman hapten, Biochemistry, 8, 4149, 1969.
26. Alving, C. R., Kinsky, S. C., Haxby, J. A., and Kinsky, C. B., Antibody binding and complement fixation by a liposomal model membrane, Biochemistry, 8, 1582, 1969.
27. Kinsky, S. C., Antibody-complement interaction with lipid model membranes, Biochim. Biophys. Acta, 265, 1, 1972.
28. Banerji, B. and Alving, C. R., Anti-liposome antibodies induced by lipid A. I. Influence of ceramide, glycosphingolipids, and phosphocholine on complement damage, J. Immunol., 126, 1080, 1981.
29. Banerji, B., Lyon, J. A., and Alving, C. R., Membrane lipid composition modulates the binding specificity of a monoclonal antibody against liposomes, Biochim. Biophys. Acta, 689, 319, 1982.
30. Strejan, G. H., Essani, K., and Surlan, D., Naturally occurring antibodies to liposomes. II. Specificity and electrophoretic pattern of rabbit antibodies reacting with sphingomyelin-containing liposomes, J. Immunol., 127, 160, 1981.
31. Akots, G., Braman, J. C., Broeze, R. J., and Bowden, D. W., Rapid, homogeneous phase, liposome-based assays for total complement activity, Complement, 1, 125, 1984.
32. Szebeni, J., Wassef, N. M., Rudolph, A. S., and Alving, C.R., Activation of complement by liposome-encapsulated hemoglobin in human serum in vitro: The roles of natural anti-phospholipid antibodies, Biochim. Biophys. Acta, 1285, 127, 1996.
33. Wassef, N. M., Roerdink, F., Swartz, G. M., Lyon J. A., Berson, B. J., and Alving, C. R., Phosphate-binding specificities of monoclonal antibodies against phosphoinositides in liposomes, Mol. Immunol., 21, 863, 1984.
34. Thielens, N. M. and Colomb, M. G., A model system for the study of the assembly and regulation of human complement C3 convertase (classical pathway), Eur. J. Immunol., 16, 617, 1986.
35. Mold, C., Cooper, N. R., and Nemerow, G. R., Incorporation of the purified Epstein-Barr virus/C3d receptor (CR2) into liposomes and demonstration of its dual ligand binding functions, J. Immunol., 136, 4140, 1986.
36. Nemerow, G. R., Mold, C., Schwend, V. K., Tollefson, V., and Cooper, N. R., Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: Sequence homology of gp350 and C3 complement fragment C3d, J. Virol., 61, 1416, 1987.
37. Humphrey J. H., The nature of complement-induced lesions in membranes, Hæmatologia, 6, 319, 1972.
38. Silversmith, R. E. and Nelsestuen, G. L., Assembly of the membrane attack complex of complement on small unilamellar phospholipid vesicles, Biochemistry, 25, 852, 1986.
39. Silversmith, R. E. and Nelsestuen, G. L., Interaction of complement proteins C5b-6 and C5b-7 with phospholipid vesicles: Effects of phospholipid structural features, Biochemistry, 25, 7717, 1986.
40. Shiver, J. W., Dankert, J. R., Donovan, J. J., and Esser, A. F., The ninth component of human complement(C9). Functional activity of the b fragment, J. Biol. Chem., 261, 9629, 1986.
41. Zalman, L. S., Wood, L. M., and Muller-Eberhard, H. J., Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels, Proc. Natl. Acad. Sci. USA, 83, 6975, 1986.
42. Zalman, L. S., Brothers, M. A., Chiu, F. J., and Muller-Eberhard, H. J., Mechanism of cytotoxicity of human large granular lymphocytes: Relationship of the cytotoxic lymphocyte protein to the ninth component (C9) of human complement, Proc. Natl. Acad. Sci. USA, 83, 5262, 1986.
43. Liu, Z. Y., Solow, R., and Hu, V. W., Fluorescence analysis of size distribution and mode of dye release from carboxyfluorescein-loaded vesicles: Application to the study of complement-membrane interactions, Biochim. Biophys. Acta, 945, 253, 1988.
44. Van der Meer, B. W., Fugate, R. D., and Sims, P. J., Complement proteins C5b-9 induce transbilayer migration of membrane phospholipids, Biophys. J., 56, 935, 1989.
45. Alving, C. R., Natural antibodies against phospholipids and liposomes in humans, Biochem. Soc. Trans., 12, 342, 1984.
46. Alving, C. R. and Swartz, G. M., Antibodies to cholesterol, cholesterol conjugates, and liposomes: Implications for atherosclerosis and autoimmunity, Crit. Rev. Immunol., 10, 441, 1991.
47. Alving, C. R., Swartz, G. M., and Wassef, N. M., Naturally occurring autoantibodies to cholesterol in humans, Biochem. Soc. Trans., 17, 637, 1989.
48. Wassef, N. M. Johnson, S. H., Graeber, G. M., Swartz, G. M., Schultz, C. L., Hailey, J. R., Johnson, A. J., Taylor, D. G., Ridgway, R. L., and Alving, C. R., Anaphylactoid reactions mediated by autoantibodies to cholesterol in miniature pigs, J. Immunol., 143, 2990, 1989.
49. Wassef, N. M., Swartz, G. M., Berman J. D., Wilhelmsen, C. L., and Alving, C. R., Toxic effects of antileishmanial reverse-phase evaporation liposomes containing dicetyl phosphate in monkeys, Drug Delivery, 2, 181, 1995.
50. Szebeni, J., Wassef, N. M., Spielberg, H., Rudolph, A. S., and Alving, C. R., Complement activation in rats by liposomes and liposome-encapsulated hemoglobin: Evidence for anti-lipid antibodies and alternative pathway activation, Biochem. Biophys. Res. Comm., 205, 255, 1994.
51. Szebeni, J., Wassef, N. M., Rudolph, A. S., and Alving, C. R., Complement activation by liposome-encapsulated hemoglobin in vitro: The role of endotoxin contamination, Artif. Cells Blood Subs. and Immob. Biotechnol., 23, 355, 1995.
52. Szebeni, J., Spielberg, H., Cliff, R. O., Wassef, N. M., Rudolph, A. S., and Alving, C. R., Complement activation and thromboxane secretion by liposome-encapsulated hemoglobin in rats in vivo: Inhibition by soluble complement receptor type 1, Artif. Cells Blood Subs. and Immob. Biotechnol., 25, 347, 1997.
53. Comis, A. and Easterbrook Smith, S. B., Inhibition of serum complement haemolytic activity by lipid vesicles containing phosphatidylserine, FEBS Lett., 197, 321,1986.
54. Okada, N., Yasuda, T., Tsumita, T., and Okada, H., Activation of the alternative complement pathway of guinea-pig by liposomes incorporated with trinitrophenylated phosphatidylethanolamine, Immunology, 45, 115, 1982.
55. Okada, N., Yasuda, T., Tsumita, T., and Okada, H., Differing reactivities of human and guinea-pig complement on haptenized liposomes via the alternative pathway, Mol. Immunol., 20, 857, 1983.
56. Okada, N., Yasuda, T., Tsumita, T., and Okada, H., Activation of the alternative complement pathway by natural antibody to glycolipids in guinea-pig serum, Immunology, 50, 75, 1983.
57. Okada, H., Okada, N., and Yasuda, T., Activation of the alternative complement pathway by IgM antibody reacted on paragloboside incorporated into liposome membrane, Mol. Immunol., 20, 499, 1983.
58. Li, Y. P., Mold, C., and Du Clos, T. W., Sublytic complement attack exposes C-reactive protein binding sites on cell membranes, J. Immunol., 152, 2995, 1994.
59. Tsujimoto, M., Inoue, K., and Nojima, S., Reactivity of human C-reactive protein with positively charged liposomes, J. Biochem., 90, 1507, 1981.
60. Mold, C. and Gewurz, H., Inhibitory effect of C-reactive protein on alternative C pathway activation by liposomes and Streptococcus pneumoniæ, J. Immunol., 127, 2089, 1981.
61. Volanakis, J. E. and Narkates, A. J., Interaction of C-reactive protein with artificial phosphatidylcholine bilayers and complement, J. Immunol., 126, 1820, 1981.
62. Kovacsovics, T., Tschopp, J., Kress, A., and Isliker, H., Antibody-independent activation of C1, the first component of complement, by cardiolipin, J. Immunol., 135, 2695, 1985.
63. Turner, M. W., Mannose binding lectin: The pluripotent molecule of the innate immune system. Immunol. Today, 17, 532, 1996.
64. Moore, F. D., Fearon, D. T., and Austen, K. F., IgG on mouse erythrocytes augments activation of the human alternative complement pathway by enhancing deposition of C3b, J. Immunol., 126, 1805, 1381.
65. Moore, F. D. J., Austen, K. F., and Fearon, D. T., Antibody restores human alternative complement pathway activation by mouse erythrocytes rendered functionally deficient by pretreatment with pronase, J. Immunol., 128, 1302, 1982.
66. Lutz, H. U., Bussolino, F., Flepp, R., Fassler, S., Stammler, P., Kazatchkine, M. D., and Arese, P., Naturally occurring anti-barid-3 antibodies and complement together mediate phagocytosis of oxidatively stressed human erythrocytes, Proc. Natl. Acad. Sci. USA, 84, 7368, 1984.
67. Lutz, H. U., Bussolino, F., Flepp, R., Fasler, S., Stammler, P., Kazatchkine, M. D., and Arese P., Naturally occurring anti-band-3 antibodies and complement together mediate phagocytosis of oxidatively stressed human erythrocytes, Proc. Natl. Acad. Sci., 84, 7368. 1987.
68. Lutz, H. U., Fasler, S., Stammler, P., Bussolino, F., and Arese, P., Naturally occurring anti-band 3 antibodies and complement in phagocytosis of oxidatively stressed and in clearance of senescent red cells, Blood Cells, 14, 175, 1988.
69. Lutz, H. U., Stammler, P., and Fasler, S., How naturally occurring anti-band 3 antibodies stimulate C3b deposition to senescent and oxidatively stressed red blood cells, Biomed. Biochim. Acta, 49, S224, 1990.
70. Lutz, H. U., Erythrocyte clearance, in Blood Cell Biochemistry, Volume 1: Erythroid Cells, Harris, J. R., Ed., London: Plenum Press, 1990, 81.
71. Okada, N., Yasuda, T., Tsumita, T., and Okada, H., Activation of the alternative complement pathway by natural antibody to glycolipids in guinea-pig serum, Immunology, 50, 75, 1983.
72. Wassef, N. M. and Alving, C. R., Complement-dependent phagocytosis of liposomes by macrophages, Methods Enzymol., 149, 124, 1987.
73. Wassef, N. M., Matyas, G. R., and Alving, C. R., Complement- dependent phagocytosis of liposomes by macrophages: Suppressive effects of "stealth" lipids, Biochem. Biophys. Res. Comm., 176, 866, 1991.
74. Wassef, N. M. and Alving, C. R., Complement-dependent phagocytosis of liposomes. Chem. Phys. Lipids, 64, 239, 1993.
75. Matsuo, H., Funato, K., Harashima, H.,and Kiwada, H., The complement- but not man-nose receptor-mediated phagocytosis is involved in the hepatic uptake of cetylmannoside-modified liposomes in situ, J. Drug Target., 2, 141, 1994.
76. Liu, D., Liu, F., and Song, Y. K., Recognition and clearance of liposomes containing phosphatidylserine are mediated by serum opsonin, Biochim. Biophys. Acta, 1235, 140, 1995.
77. Richards, R. L., Habbersett, R. C., Scher, I., Janoff, A. S., Schieren, H. P., Mayer, L. D., Cullis, P. R., and Alving, C. R., Influence of vesicle size on complement- dependent immune damage to liposomes, Biochim. Biophys. Acta, 855, 223, 1986.
78. Salama, A., Hugo, F., Heinrich, D., Hoge, R., Muller, R., Kiefel, V., Mueller-Eckhardt, C., and Bhakdi, S., Deposition of terminal C5b-9 complement complexes on erythrocytes and leukocytes during cardiopulmonary bypass,N. Eng. J. Med., 318, 408, 1988.
79. Miyamoto, K., Schultz, E., Heath,T., Mitchel, M. D., Albertine, K. H., and Staub, N. C., Pulmonary intravascular macrophages and hemodynamic effects of liposomes in sheep, J. Appl. Physiol., 64, 1143, 1988.
80. Liu, D., Liu, F., and Song, Y. K., Monosialoganglioside GM l shortens the blood circulation time of liposomes in rats, Pharm. Res., 12, 508, 1995.
81. Rabinovici, R., Rudolph, A. S., and Feuerstein, C., Characterization of hemodynamic, hematologic and biochemical responses to administration of liposome- encapsulated hemoglobin in the conscious, freely moving rat, Circ. Shock, 29, 115, 1989.
82. Rabinovici, R., Rudolph, A. S., and Feuerstein, G., Improved biological properties of synthetic distearoyl phosphatidylcholine-based liposome in the conscious rat, Circ. Shock, 30, 207, 1990.
83. Rabinovici, R., Rudolph, A. S., Yue, T.-L., and Feuerstein, G., Biological responses to liposome-encapsulated hemoglobin (LEH) are improved by a PAF antagonist, Circ. Shock, 31, 431, 1990.
84. Rabinovici, R., Rudolph, A. S., Ligler, F. S., Yue, T.-L., and Feuerstein, G., Liposome-encapsulated hemoglobin: An oxygen-carrying fluid, Circ. Shock, 32, 1, 1990.
85. Rudolph, A. S., Encapsulation of hemoglobin in liposomes, in Blood Substitutes. Physiological Basis of Efficacy, Winslow, R. M., Vandegriff, K. D. and Intaglietta, M., Eds., Boston: Birkhauser, 1995, 98.
86. Goins, B., Phillips, W. T., Klipper, R. W., and Rudolph, A. S., Indium-111- labeled platelet distribution studies in rats with transient thrombocytopenia following LEH infusion: Role of complement, Artif. Cells Blood Substit. and Immobilization Biotechnol., 24, 340, 1996.
87. Goins, B., Phillips, W. T., Klipper, R. W., and Rudolph, A. S., Role of complement in rats injected with liposome-encapsulated hemoglobin, J. Surg. Res., 68, 99, 1997.
88. Phillips, W. T., Goins, B., Klipper, R. W., Bloodworth, R. C., Meadows, R. L., Rudolph, A. S., and McManus, L. M., Intravascular arid hemodynamic effects of liposome-encapsulated hemoglobin (LEH) in the rabbit, Artif. Cells Blood Substit. and Immobilization Biotechnol., 24, 404, 1996.
89. Rudolph, A. S., Sulpizio,T., Kwasiborski, V., Cliff, R. O., Rabinovici, R.,and Feuerstein, G., Infusion of liposome encapsulated hemoglobin in normovolemic primates, Artif. Cells Blood Substit. and Immobilization Biotechnol., 24, 415, 1996.
90. Coune, A., Sculier, J. P., Frühling, J., Stryckmans, P., Brassine, C., Ghanem, G., Laduron, C., Atassi, G., Ruysschaert, J. M., and Hildebrand, J., IV administration of a water-insoluble antimitotic compound entrapped in liposomes. Preliminary report on infusion of large volumes of liposomes to man, Cancer Treat. Rep., 67, 1031, 1983.
91. Sculier, J. P., Coune, A., Brassinne, C., Laduron, C., Atassi, G., Ruysschaert, J. M., and Fruhling, J., Intravenous infusion of high doses of liposomes containing NSC 251635, a water-insoluble cytostatic agent. A pilot study with pharmacokinetic data, J. Clin. Oncol., 4, 789, 1986.
92. Levine, S. J., Walsh, T. J., Martinez, A., Eichacker, P. Q., Lopez- Berstein, G., and Natanson, C., Cardiopulmonary toxicity after liposomal amphotericin B infusion, Annals Int. Med., 114, 664, 1991.
93. Laing, R. B. S., Milne, L. J. R., Leen, C. L. S., Malcolm, G. P., and Steers, A. J. W., Anaphylactic reactions to liposomal amphotericin, Lancet, 344, 682, 1994.
94. Ringdén, O., Andström, E., Remberger, M., Svahn, B. M., and Tollemar, J., Allergic reactions and other rare side effects of liposomal amphotericin, Lancet, 344, 1156, 1994.
95. de Marie, S., Liposomal and lipid-based formulations of amphotericin B, Leukemia, 10, Suppl. 2., 893, 1996.
96. Uziely, B., Jeffers, S., Isacson, R., Kutsch, K., Wei-Tsao, D., Yehoshua, Z., Libson, E., Muggia, F. M., and Gabizon, A., Liposomal doxorubicin: Antitumor activity and unique toxicities during two complementary phase I studies, J. Clin. Oncol., 13. 1777, 1995.
97. Chenoweth, D. E., Cooper, S. W., Hugli, T. E., Stewart, R. W., Blackstone, E. H., and Kirklin, J. W., Complement activation during carcliopulmonary bypass: Evidence for generation of C3a and C5a anaphylatoxiris, N. Engl. J. Med., 304, 497, 1981.
98. Cheung, A. K., The complement system in extracorporeal circulation, Plasma Ther. Transf. Technol., 5, 505, 1984.
99. Montdargent, B., Toufik, J., Carreno, M. P., Labarre, D., and Jozefowicz, M., Complement activation and adsorption of protein fragments by functionalized polymer surfaces in human serum,Biomaterials, 13, 571, 1992.
100. Kubatiev, A., Rudko, I., and Ermolenko, V., Complement activation and neutrophil aggregation changes during hemodialysis, Int. J. Clin. Pharm. Res., 13, 293, 1993.
101. Skroeder, N. R., Jacobson, S. H., Lins, L. E., and Kjellstrand, C. M., Acute symptoms during and between hemodialysis: The relative role of speed, duration, and biocompatibility of dialysis, Artif. Organs, 18, 880, 1994.
102. Skroeder, N. R., Kjellstrand, P., Holmquist, B., Kjellstrand, C. M., and Jacobson, S. H., Individual differences in biocompatibility responses to hemodialysis, Int. J. Artif. Organs, 17, 521, 1994.
103. Skroeder, N. R., Kjellstrand, P., Holmquist, B., Kjellstrand, C. M., and Jacobson, S. H., On complement net generation in fast hemolysis: Are high blood flow rates biocompatible? Am. J. Kidney Dis., 25, 896, 1995.
104. Videm, V. and Mollnes, T. E., Human complement activation by polygeline and dextran 70, Scand. J. Immunol., 39, 314, 1994.
105. Shur, P. H., Complement studies of sera and other biologic fluids, Hum. Pathol., 14, 338, 1983.
106. Tomasko, M. A., Chudwin, D. S., Complement activation in sickle cell disease: A liposome model, J. Lab. Clin. Med., 112, 248, 1988.
107. Buyon, J. P., Tamerius, J., Belmont, H. M., and Abramson, S. B., Assessment of disease activity and impending flare in patients with systemic lupus erythematosus. Comparison of the use of complement split products and conventional measurements of complement, Arthritis. Rheum., 35, 1028, 1992.
108. Buyon, J. P., Tamerius, J., Ordorica, S., Young, B., and Abramson, S. B., Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy, Arthritis. Rheum., 35, 55, 1992.
109. Morgan, B. P. and Walport, M. J., Complement deficiency and disease, Immunol. Today, 12, 301, 1991.
110. Duchateau, J., Haas, M., Schreyen, H., Radoux, L., Sprangers, I., Noel, F. X., Braun, M., and Lamy, M., Complement activation in patients at risk of developing the adult respiratory distress syndrome, Am. Rev. Respir. Dis., 130, 1058, 1984.
111. Borg, T., Gerdin, B., Hallgren, R., and Modig, J., The role of polymorphonuclear leukocytes in the pulmonary dysfunction induced by complement activation, Acta Anaesthesiol. Scand., 29, 231, 1985.
112. Gallinaro, R., Cheadle, W. G., Applegate, K., and Polk, H. C., The role of the complement system in trauma and infection, Surgery, 174, 435, 1992.
113. Hammerschmidt, D. E., Hudson, L. D., Weaver, L. J., Craddock, P. R., and Jacob, H. S., Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome, Lancet, May 3, 947, 1980.
114. Heideman, M. and Hugli, T. E., Anaphylatoxin generation in multisystem organ failure, J. Trauma, 24, 1038, 1984.
115. Hammerschmidt, D. E., Activation of complement and granulocytes in shock, in Complement in Health and Disease, Whaley, K., Ed., Lancaster/Boston: MTP Press, 1986, 267.
116. Rabinovici, R., Yeh, G. G., Hillegass, L. M., Griswold, D. E., Di Martino, M. J., Vernick, J., Fong, K.-L. L., and Feuerstein, G., Role of complement in endotoxin/platelet-activating factor-induced lung injury, J. Immunol., 149, 1744, 1992.
117. Moore, F. D., Therapeutic regulation of the complement system in acute injury states. Adv. Immunol., 56, 267, 1994.
118. Hugli, T. E., Structure arid function of anaphylatoxins, Spring. Semin. Immunopathol., 7, 193, 1984.
119. Marceau, F., Lundberg, C., and Hugli, T. E., Effects of anaphylatoxins on circulation, Immunopharmacol., 14, 67, 1987.
120. Chang, T. M. S. and Lister, C. W., Assessment of blood substitutes. II. In-vitro complement activation of human plasma and blood for safety studies in research, development, industrial production and preclinical analysis, Art. Cells, Blood Subs., and Immob. Biotech., 22, 171, 1994.
121. Labarre, D., Montdargent, B., Carreno, M.-P., and Maillet, F., Strategy for in vitro evaluation of the interactions between biomaterials and complement system, J. Appl. Biomat., 4, 231, 1993.
122. Okada, N., Yasuda, T., Tsumita, T., Shinomiya, H., Utsumi, S., and Okada, H., Regulation of glycophorin of complement activation via the alternative pathway, Biochem. Biophys. Res. Commun., 108, 770, 1982.
123. Okada, N., Yasuda, T., Tsumita, T., and Okada, H., Membrane sialoglycolipids regulate the activation of alternative complement pathway by liposomes containing trinitrophenyl-aminocaproyldipalmitoylphosphatidylethaolamine, Immunology, 48, 129, 1983.
124. Okada, N., Yasuda, T., and Okada, H., Antibody-mediated alternative complement pathway activation resists inhibition by sialoglycolipids, J. Immunol., 134, 3316, 1985.
125. Shichijo, S. and Alving, C. R., Inhibitory effects of gangliosides on immune reactions of antibodies to neutral glycolipids in liposomes, Biochim. Biophys. Acta, 858, 118, 1986.
126. Michalek, M. T., Bremer, E. G., and Mold, C., Effect of gangliosides on activation of the alternative pathway of human complement, J. Immunol., 140, 1581, 1988.
127. Michalek, M. T., Mold, C., and Bremer, E. G., Inhibition of the alternative pathway of human complement by structural analogues of sialic acid, J. Immunol., 140, 1588, 1988.
128. Schieren, G. and Hänsch, G. M., Membrane-associated proteins regulating the complement system: Functions arid deficiencies, Int. Rev. Immunol., 10, 87, 1993.
129. Kazatchkine, M. D., Fearon, D. T., Silbert, J. E., and Austen, K. F., Surface-associated heparin inhibits zymosan-induced activation of the human alternative pathway by augmenting the regulatory action of control proteins on particle-bound C3b, J. Exp. Med., 150, 1202, 1970.
130. Bhakdi, S., Maillet, F., Muhly, M., and Kazatchkine, M. D., The cytolytic C5b-9 complement complex: Feedback inhibition of complement activation, Proc. Natl. Acad. Sci. USA, 85, 1912, 1988.
131. Funato, K., Yoda, R., and Kiwada, H., Contribution of complement system on destabilization of liposomes composed of hydrogenated egg phosphatidylcholine in rat fresh plasma, Biochim. Biophys. Acta, 1103, 198, 1992.
132. Vogt, W., Drugs and the complement system, Trends Pharm. Sci., 114, 1985.
133. Gibb, A. L., Freeman, A. M., Smith, R. A., Edmonds, S., and Sim, E., The interaction of soluble human complement receptor type 1 (sCR1, BRL55730) with human complement component C4, Biochim. Biopkys. Acta, 1180, 313, 1993.
134. Cheung, A. K., Parker, C. J., and Hohnholt, M., Soluble complement receptor type 1 inhibits complement activation induced by hemodialysis membranes in vitro, Kidney Int., 46, 1680, 1994.
135. Weisman, H. F., Bartow, T., Leppo, M. K., Marsh, H. C. J., Carson, G. R., Concino, M. F., Boyle, M. P., Roux, K. H., Weisfeldt, M. L., and Fearon, D. T., Soluble complement receptor type 1 : In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis, Science, 249, 146, 1990.
136. Gillinov, A. M., De Valeria, P. A., Winkelstein, J. A., Wilson, I., Curtis, W. E., Shaw, D., Yeh, C. G., Rudolph, A. R., Baumgartner, W. A., and Herskowitz, A., Complement inhibition with soluble complement receptor type 1 in cardiopulmoriary by pass, Ann. Thorac. Surg., 55, 619, 1993.
137. Homeister, J. W., Satoh, P. S., Kilgore, K. S., and Lucchesi, B. R., Soluble complement receptor type 1 prevents human complement-mediated damage of the rabbit isolated heart, J. Immunol., 150, 1055, 1993.
138. Pruitt, S. K., Kirk, A. D., Bollinger, R. R., Marsh, H. C. Jr., Collins, B. H., Levin, J. L., Mault, J. R., Heinle, J. S., Ibrahim, S., Rudolph, A. R., Baldwin, W. M., and Sanfilippo, F., The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts, Transplantation, 57, 363, 1994.
139. Chavez-Cartaya, R. E., DeSola, G. P., Wright, L., Jamieson, N. V., and White, D. J., Regulation of the complement cascade by soluble complement receptor type 1. Protective effect in experimental liver ischemia and reperfusion, Transplantation, 59, 1047, 1995.
140. Kinsky, S. C., Bonsen, P. P., Kinsky, C. B., Van Deenen, L. L., and Rosenthal, A. F., Preparation of immunologically responsive liposomes with phosphonyl and phosphinyl analogs of lecithin, Biochim. Biophys. Acta, 233, 815, 1971.
141. Loughrey, H. C., Bally, M. B., Reinish, L. W., and Cullis, P. R., The binding of phosphatidylglycerol liposomes to rat platelets is mediated by complement, Thromb. Haemostasis, 64, 172, 1990.
142. Marjan, J., Xie, Z., and Devine, D. V., Liposome-induced activation of the classical complement pathway does not require immunoglobulin, Biochim. Biophys. Acta, 1192, 35, 1994.
143. Knudson, K. C., Bing, D. H., and Kater, L., Quantitative measurement of guinea pig complement with liposomes, J. Immunol., 106, 258, 1971.
144. Kataoka, T., Inoue, K., Luderitz, O., and Kinsky, S. C., Antibody- and complement-dependent damage to liposomes prepared with bacterial lipopolysaccharides. Eur. J. Biochem., 21, 80, 1971.
145. Kataoka,T., Inouse. K., Galanos, C., and Kinsky, S. C., Detection and specificity of lipid A antibodies using liposomes sensitized with lipid A and bacterial lipopolysaccharides, Eur. J. Biochem., 24, 123, 1971.
146. Alving, C. R. and Kinsky, S. C., The preparation and properties of liposomes in the LA and LAC states, Immunochemistry, 8, 325, 1971.
147. Inoue, K., Kataoka, T., and Kinsky, S. C., Comparative responses of liposomes prepared with different ceramide antigens to antibody and complement, Biochemistry, 10, 2574, 1971.
148. Uemura, K. and Kinsky, S. C., Active vs. passive sensitization of liposomes toward antibody and complement by dinitrophenylated derivatives of phosphatidylethanolamine, Biochemistry, 11, 4085, 1972.
149. Six, H. R., Uemura, K. I., and Kinsky, S. C., Effect of immunoglobulin class and affinity on the initiation of complement-dependent damage to liposomal model membranes sensitized with dinitrophenylated phospholipids, Biochemistry, 12, 4003, 1973.
150. Kataoka, T., Williamson, J. R., and Kinsky, S. C., Release of macromolecular markers (enzymes) from liposomes treated with antibody and complement. An attempt at correlation with electron microscopic observations, Biochim. Biophys. Acta, 298, 158, 1973.
151. Alving, C. R., Joseph, K. C., Lindsley, H. B., and Schoenbechler, M. J., Immune damage to liposomes containing lipids from Schistosoma mansoni worms (38125), Proc. Soc. Exp. Biol. Med., 146, 458, 1974.
152. Six, H. R., Young, W. Jr., Uentura, K., and Kinsky, S. C., Effect of antibody-complement on multiple vs. single compartment liposomes. Application of a fluorometric assay for following changes in liposomal permeability, Biochemistry, 13, 4050, 1974.
153. Humphries, G. K. and McConnell, H. M., Immune lysis of liposomes and erythrocyte ghosts loaded with spin label, Proc. Natl. Acad. Sci. USA, 71, 1691, 1974.
154. Joseph, K. C., Alving, C. R., and Wistar, R., Forssman-containing liposomes: Complement-dependent damage due to interaction with a monoclonal IgM, J. Immunol., 112, 1949, 1974.
155. Alving, C. R., Joseph, K. C., and Wistar, R., Influence of membrane composition on the interaction of a human monoclonal anti-Forssman immunoglobulin with liposomes, Biochemistry, 13, 4818, 1974.
156. Alving, C. R., Fowble, J. W., and Joseph, K. C., Comparative properties of four galactosyl lipids as antigens in liposomes, Immunochemistry, 11, 475, 1974.
157. Humphries, G. M. and McConnell, H. M., Antigen mobility in membranes and complement-medical immune attack, Proc. Natl. Acad. Sci. USA, 72, 2483, 1975.
158. Alving, C. R., Conrad, D. H., Gockerman, J. P., Gibbs, M. B., and Wirtz, G. H., Vitamin A in liposomes. Inhibition of complement binding and alteration of membrane structure, Biochim. Biophys. Acta, 394, 157, 1975.
159. Moss, J., Fishman, P. H., Richards, R. L., Alving, C. R.,Vaughan, M., and Brady, R. O., Choleragen-mediated release of trapped glucose from liposomes containing ganglioside GM1, Proc. Natl. Acad. Sci. USA, 73, 3480, 1976.
160. Ruysschaert, J. M., Tenenbaum, A., Berliner, C., and Delmelle, M., Correlation between lateral lipid phase separation and immunological recognition in sensitized liposomes, FEBS Lett., 81, 406, 1977.
161. Kinoshita, T., Inoue, K., Okada, M., and Akiyama, Y., Release of phospholipids from liposomal model membrane damaged by antibody and complement, J. Immunol., 119, 73, 1977.
162. Richards, R. L., Gewurz, H., Osmand, A. P., and Alving, C. R., Interactions of C-reactive protein and complement with liposomes, Proc. Natl. Acad. Sci. USA, 74, 5672, 1977.
163. Rosenqvist, E. and Vistnes, A. I., Immune lysis of spin label loaded liposomes incorporating cardiolipin; a new sensitive method for detecting anticardiolipin antibodies in syphilis serology, J. Immunol. Methods, 15, 147, 1977.
164. Humphries, G. M. and McConnell, H. M., Membrane-controlled depletion of complement activity by spin-label-specific IgM, Proc. Natl. Acad. Sci. USA, 74, 3537, 1977.
165. Geiger, B. and Smolarsky, M., Immunochemical determination of ganglioside GM2, by inhibition of complement-dependent liposome lysis, J. Immunol. Methods, 17, 7, 1977.
166. Moss, J., Richards, R. L., Alving, C. R., and Fishman, P. H., Effect of the A and B protomers of choleragen on release of trapped glucose from liposomes containing or lacking ganglioside GM1, J. Biol. Chem., 252, 797, 1977.
167. Willoughby, E. M., Turner, M. J., and Sanderson, A. R., Incorporation of rat histocompatibility (AgB) antigens into liposomes, and their susceptibility to immune lysis, Eur. J. Immunol., 8, 628, 1978.
168. Mayer, M. M., Hammer, C. H., Michaels, D. W., and Shin, M. L., Immunologically mediated membrane damage: The mechanism of complement action and the similarity of lymphocyte-mediated cytoxicity, Immunochemistry, 15, 813, 1978.
169. Esser, A. F., Bartholomew, R. M., Parce, J. W., and McConnell, H. M., The physical state of membrane lipids modulates the activation of the first component of complement, J. Biol. Chem., 254, 1768, 1979.
170. Strejan, G. H., Smith, P. M., Grant, C. W., and Surlan, D., Naturally occurring antibodies to liposomes. I. Rabbit antibodies to sphingomyelin-containing liposomes before and after immunization with unrelated antigens, J. Immunol., 123, 370, 1979.
171. Cunningham, C. M., Kingzette, M., Richards, R. L., Alving, C. R., Lint, T. F., and Gewurz, H., Activation of human complement by liposomes: A model for membrane activation of the alternative pathway, J. Immunol., 122, 1237, 1979.
172. Richards, R. L., Gewurz, H., Siegel, J., and Alving, C. R., Interactions of C-reactive protein and complement with liposomes, J. Immunol., 122, 1185, 1979.
173. Yasuda, T., Naito, Y., Tsumita, T., and Tadakuma, T., A simple method to measure antiglycolipid antibody by using complement-mediated immune lysis of fluorescent dye-trapped liposomes, J. Immunol. Methods, 44, 153, 1981.
174. Das, M. K., Roy, S. K., and Sarkar, D. P., Characterization of anti-N-acetyl-D-glucosamine antibodies elicited through haptenated liposomes, Carbohydr. Res., 128, 335, 1984.
175. Ishimori, Y., Yasuda, T., Tsumita, T., Notsuki, M., Koyama, M., and Tadakuma, T., Liposome immune lysis assay (LILA): A simple method to measure anti-protein antibody using protein antigen-bearing liposomes, J. Immunol. Methods, 75, 351, 1984.
176. Shichijo, S., Toffano, G., and Alving, C. R., Complement-dependent immune damage to liposomes containing gangliosides, J. Immunol. Methods, 85, 53, 1985.
177. DuPont, B. L., Koethe, S. M., and McQuillen, M. P., Complement activation in myasthenia gravis plasma by Torpedo acetylcholine receptor liposomes, Immunol. Invest., 14, 415, 1985.
178. Mold, C., Effect of membrane phospholipids on activation of the alternative complement pathway, J. Immunol., 143, 1663-1668, 1989.
179. Crook, S. J., Boggs, J. M., Vistnes, A. I., and Koshy, K. M., Factors affecting surface expression of glycolipids: Influence of lipid environment and ceramide composition on antibody recognition of cerebroside sulfate in liposomes, Biochemistry, 25, 7488, 1986.
180. Okada, N., Yasuda, T., and Okada, H., Binding of C3 molecules to membranes via the SH-residue generated by the cleavage of a thioester bond can initiate complement activation, Biochtm. Biophys. Res. Commun., 151, 743, 1988.
181. Masaki, T., Okada, N., Yasuda, R., and Okada, H., Assay of complement activity in human serum using large uriilamellar liposomes, J. Immunol. Methods, 123, 1, 1989.
182. Vistnes, A. I., A new method of evaluating complement mediated lysis of liposomes, J. Immunol. Methods, 68, 251-261, 1984.
183. Umeda, M., Ishimori, Y., Yoshikawa, K., Takada, M., and Yasuda, T., Liposome immune lysis assay (LILA). Application of sandwich method to determine a serum protein component with antibody-bearing liposomes, J. Immunol. Methods, 95, 15, 1986.
184. Bowden, D. W., Rising, M., Akots, G., Myles, A., and Breeze, R. J., Homogeneous, liposome-based assay for total complement activity in serum, Clin. Chem., 32, 275, 1986.
185. Motoda, S., A complement-mediated immune lysis test using liposomes for the detection of antibodies to Mycoplasma pneumoniae, Nippon Saikingaku Zasshi, 41, 757, 1986.
186. Yu, B. S., Choi, Y. K., and Chung, H. H., Development of immunoassay methods by use of liposomes, Biotechnol. Appl. Biochem., 9, 209, 1987.
187. 4Cer, J. Biochem., 102, 59, 1987.
188. Ligler, F. S., Bredehorst, R., Talebian, A., Shriver, L. C., Hammer, C. F., Sheridan, J. P., Vogel, C. W., and Gaber, B. P., A homogeneous immunoassay for the mycotoxin T-2 utilizing liposomes, monoclonal antibodies, and complement, Anal. Biochem., 163, 369, 1987.
189. Legros, F., Castillo, M., Praet, M., Vandenbranden, M., Lemoine, O., Cabiaux, V., Van Vooren, J.-P., Nyabenda, J., Dierckx, P., Turneer, M., and Ruysschaent, J. M., Detection of lytic antimycobacterial antibodies by immune lysis of liposomes sensitized to tuberculin, J. Immunol. Methods, 108, 223, 1988.
190. Legros, F., Schietecat, P., Leroy, C. P., and Van Vooren, J. P., An automated micromethod for detection of lytic antimycobacterial antibodies by immune lysis of liposomes sensitized to tuberculin, J. Immunoassay, 10, 359, 1989.
191. Kim, C. K. and Lim, S. J., Liposome immunoassay (LIA) with antigen-coupled liposomes containing alkaline phosphatase, J. Immunol. Methods, 159, 101, 1993.
192. Locascio-Brown, L., Plant, A. L., Chesler, R., Kroll, M., Ruddel, M., and Durst, R. A., Liposome-based flow-injection immunoassay for determining theophylline in scrum, Clin. Chem., 39, 386, 1993.
193. Skopinskaia, S. N., Tamulevich, I., larkov, S. P., Zlobin, V. N., and Kalinin, I., A highly sensitive, homogeneous method for determining antibodies and antigens by using liposomes, monoclonal antibodies and complement, Zh. Mikrobiol. Epidemiol. Immunobiol., 1, 77, 1993.
194. Yamamoto, S., Kubotsu, K., Kida, M., Kondo, K., Matsuura, S., Uchiyama, S., Yonekawa, O., and Kanno, T., Automated homogenous liposome-based assay system for total complement activity, Clin. Chem., 41, 586, 1995.